EQT Life Sciences

General contacts

Investor type

Founded

1987

AUM

$2 690 000 M

Location

Amsterdam, North Holland, Netherlands

Investment Ticket

$10-50 m

Investment Stage

Pre-seed Seed

Region of investment

North America Europe

Investor profile last updated: 27 August, 2026

Profile

EQT Life Sciences is a prominent life sciences investor based in Europe. The firm has a team of experienced investment professionals with backgrounds in medicine, science, and industry, focusing on innovative companies that aim to improve patient outcomes. EQT Life Sciences differentiates itself by not only providing capital but also offering strategic, clinical, operational, financial, and commercial support to its portfolio companies.

The firm invests in various sectors within life sciences, including therapeutics, medical devices, diagnostics, and healthtech. Their investment range is between 10-60 million EUR, and they target companies at all stages of development. EQT Life Sciences has raised approximately 3.5 billion EUR across 12 funds, demonstrating a strong commitment to backing innovative solutions that address unmet medical needs globally.

Notable investments include Amolyt Pharma - rare endocrine disorders, Neuravi - stroke treatment innovation, New Amsterdam Pharma - novel therapeutics, Onera Health - health monitoring solutions, and PanTera - advanced healthcare technologies. These companies reflect EQT Life Sciences' dedication to transforming scientific innovation into impactful healthcare solutions.

Industry

Food and Beverage Foodtech Healthcare Services Robotics SaaS Software Energy CleanTech HealthTech Industrial Technology Life Sciences

EQT Life Sciences Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
LSP Health Economics Fund II	Fund of funds	Healthcare Services Industrial Technology Life Sciences	Seed Series A Series B	North America Europe	$5-10 m	$280 M	January 2017
LSP Medical Technology II Fund	Fund of funds	Healthcare Services Industrial Technology Life Sciences	Seed Series A Series B	North America Europe	$5-10 m	$330 M	December 2017
LSP 6	Venture Capital (VC)	Healthcare Services Industrial Technology Life Sciences	Seed Series A Series B	North America Europe	$5-10 m	$570 M	March 2020
LSP Dementia Fund	Venture Capital (VC)	Healthcare Services Industrial Technology Life Sciences	Pre-seed Seed	North America Europe	$5-10 m	$280 M	March 2023

Contacts

Name

Title

Social Networks

Jonah Bookman Vice President of Digital Growth

Vice President of Digital Growth

j•••@•••

Francesco Starace Partner

Partner

f•••@•••

Upgrade to see contacts

t9zRgYOVvEI6h8bF t9zRgYOVvEI6h8bF

t9zRgYOVvEI6h8bF

[email protected]

t9zRgYOVvEI6h8bF t9zRgYOVvEI6h8bF

t9zRgYOVvEI6h8bF

[email protected]

t9zRgYOVvEI6h8bF t9zRgYOVvEI6h8bF

t9zRgYOVvEI6h8bF

[email protected]

Investment-team contacts for EQT Life Sciences — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about EQT Life Sciences

Is EQT Life Sciences a venture capital or private equity firm?

EQT Life Sciences is a venture capital firm. It backs companies at Pre-seed and Seed, writing tickets of $10-50 m.

Where is EQT Life Sciences located?

EQT Life Sciences is located in Amsterdam, North Holland, Netherlands.

When was EQT Life Sciences founded?

EQT Life Sciences was founded in 1987.

What sectors and industries does EQT Life Sciences invest in?

EQT Life Sciences invests in companies and startups in Food and Beverage, Foodtech, Healthcare Services, Robotics, SaaS, Software, Energy, CleanTech, HealthTech, Industrial, Technology, Life Sciences.

What is EQT Life Sciences geographical focus of investments?

EQT Life Sciences invests in companies and startups in North America, Europe.

At what stages of companies and startups does EQT Life Sciences typically invest in?

EQT Life Sciences invests in companies and startups at Pre-seed, Seed.

What is the usual amount of EQT Life Sciences investment?

EQT Life Sciences usually invests $10-50 m on average.

What is the amount of assets of under management (AUM) for EQT Life Sciences?

EQT Life Sciences has around $2 690 000m assets under management.

When was EQT Life Sciences last fund created?

EQT Life Sciences last fund was created/launched in 2023-03-12

What are the contacts of EQT Life Sciences?

EQT Life Sciences can be reached through its website lspvc.com/index.html, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for EQT Life Sciences — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access EQT Life Sciences data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query EQT Life Sciences directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the EQT Life Sciences profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 27 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.